Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 6 (3), 569-575, 2011-03
Elsevier BV